Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,448

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,872

Class I recallsReasonable probability of serious health consequences

24,509

Class II recallsTemporary or medically reversible health consequences

2,932

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,096 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/snack-right-super-foods-inc-dba-brads-raw-chips-recalls-brads-crunchy-kale-veggie-chips-duePublished November 2, 2026

Most affected stateHawaii 200 recalls mention this state

State: DC ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated November 6, 2026 ET

Summary (Year to date)

1,956 recalls have been announced year to date.
Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
The highest complete period was Jun 2026 (300).
Nov 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

FDA Recall TerminatedTerminated: July 5, 2024Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5555-3.

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for mechanical peel.
Published: March 10, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 5, 2024Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5554-3.

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for mechanical peel.
Published: March 10, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 5, 2024Historical recordClass II

Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), Contains: 30 Patches in in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5553-3.

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for mechanical peel.
Published: March 10, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 5, 2024Historical recordClass II

Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3.

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for mechanical peel.
Published: March 10, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 17, 2022Historical recordClass II

Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540; NDC 43598-350-01.

by Dr. Reddy's Laboratories, Inc.

Reason: Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.
Published: March 10, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 7, 2023Historical recordClass III

Atorvastatin Calcium Tablets, 40mg, packaged in a) 90-count bottles, NDC 55111-123-90; b) 500-count bottles, NDC 55111-123-05; Rx only, Mfd By: Dr. Reddy's Laboratories Limited Srikakulam - 532 409 INDIA

by Dr. Reddy's Laboratories, Inc.

Reason: Failed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and Dieto epoxy impurities
Published: March 10, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: January 21, 2022Historical recordClass III

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason: Subpotent
Published: March 10, 2021
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: September 1, 2021Historical recordClass III

Ferrara Candy Company

Product: Ferrara Candy Company assorted candy Heart Box, including La…
Reason: Undeclared ingredients on retail packaging, including but not limited to certified colors Red #40 and Blue #1
Published: March 10, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 16, 2023Historical recordClass I

Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 x 5 mL Single-Dose Vials per carton (NDC 71288-712-06), Rx only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL 60631.

by Meitheal Pharmaceuticals Inc

Reason: Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 15, 2024Historical recordClass II

Leucovorin Calcium for Injection, USP, 350 mg/vial, Rx only, labeled as a) Teva Parenteral Medicines, Inc., Irvine, CA 92618, and b) Manufactured By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, novaplus+, NDC 0703-5145-01.

by Teva Pharmaceuticals USA

Reason: Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 15, 2024Historical recordClass II

MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL), 5 mL Multiple-Dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-0063-01.

by Teva Pharmaceuticals USA

Reason: Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 15, 2024Historical recordClass II

MethyIPREDNISolone Acetate Injectable Suspension USP, 200 mg/5 mL (0 mg/mL), 5 mL Multiple-Dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-0043-01.

by Teva Pharmaceuticals USA

Reason: Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 15, 2024Historical recordClass II

MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple-Dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-0045-01.

by Teva Pharmaceuticals USA

Reason: Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 15, 2024Historical recordClass II

Leucovorin Calcium for Injection, USP, 100 mg/vial, Single-Dose Vial, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-5140-01.

by Teva Pharmaceuticals USA

Reason: Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 28, 2022Historical recordClass II

Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02.

by Areva Pharmaceuticals Inc

Reason: CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass I

ManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray, 1.3 FL OZ (40mL) bottle, 270 measured sprays, Distributed by Ndal Laboratories, 449 Alvarado St., Monterey, CA 93940 (bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA 93940 (carton); UPC 8 58631 00212 8. the Alvarado St. is for the bottle by putting "(bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA 93940 (carton); UPC 8 58631 00212 8." (according to the label)

by NDAL Mfg Inc.

Reason: Microbial Contamination of Non-Sterile Products: Product confirmed to have yeast
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 21, 2022Historical recordClass II

Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For Institutional Use Only 30-count (3 x 10 unit-dose) tablets per carton (NDC 43598-344-31); Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540; Made in India.

by Dr. Reddy's Laboratories, Inc.

Reason: Failed Dissolution Specifications
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 15, 2024Historical recordClass II

MethyIPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL, 1 mL Single-Dose Vial (NDC 0703-0051-01), packaged in 25X1ML vials per tray (NDC 0703-0051-04), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.

by Teva Pharmaceuticals USA

Reason: Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 15, 2024Historical recordClass II

Epoprostenol Sodium for Injection, 1.5 mg/vial (1,500,000 ng), 10 mL vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-1995-01.

by Teva Pharmaceuticals USA

Reason: Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Published: March 3, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 15, 2024Historical recordClass II

Vecuronium Bromide for Injection, 10 mg, 1 mg/mL when reconstituted to 10 mL, 10 mL Vial (NDC 0703-2914-01), packaged in 10 x 10 mL Vials per tray (NDC 0703-2914-03), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.

by Teva Pharmaceuticals USA

Reason: Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Published: March 3, 2021
Distribution: Nationwide

View recall →

Data last updated: November 6, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.